Human CAR T cells with cell-intrinsic PD-1 checkpoint blockade resist tumor-mediated inhibition

Following immune attack, solid tumors upregulate coinhibitory ligands that bind to inhibitory receptors on T cells. This adaptive resistance compromises the efficacy of chimeric antigen receptor (CAR) T cell therapies, which redirect T cells to solid tumors. Here, we investigated whether programmed...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Clin Invest
Päätekijät: Cherkassky, Leonid, Morello, Aurore, Villena-Vargas, Jonathan, Feng, Yang, Dimitrov, Dimiter S., Jones, David R., Sadelain, Michel, Adusumilli, Prasad S.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society for Clinical Investigation 2016
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4966328/
https://ncbi.nlm.nih.gov/pubmed/27454297
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI83092
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia